Search for: "Sanofi S A"
Results 61 - 80
of 924
Sorted by Relevance
|
Sort by Date
29 Mar 2007, 9:00 pm
Specifically, sanofi pasteur has licensed MedImmune's reverse genetics technology which provides the ability to make viruses from DNA segments. [read post]
5 Aug 2020, 10:28 am
The company’s spokesperson said that it has challenged the indictment. [read post]
17 Jul 2017, 7:52 am
” The class action “alleges that Sanofi failed to properly inform users about the drug’s potential risks for developing fetuses. [read post]
7 Feb 2023, 12:00 pm
This post explores the Third Circuit’s decision, Sanofi Adventis v. [read post]
19 Nov 2017, 9:05 pm
Sanofi that brought clarity to how the Court (and U.S. [read post]
18 May 2023, 9:28 am
Sanofi today, affirming the Federal Circuit's decision below in a unanimous opinion by Justice Gorsuch. [read post]
18 Jan 2024, 5:14 pm
Sanofi et al. [read post]
18 May 2023, 6:00 am
Sanofi (Case No. [read post]
12 Feb 2023, 9:15 am
Solicitor General’s recommendation to deny the petition. [read post]
12 Feb 2023, 9:15 am
Solicitor General’s recommendation to deny the petition. [read post]
29 Mar 2023, 8:10 am
Sanofi case. [read post]
12 Mar 2023, 8:43 pm
Sanofi. [read post]
16 Jan 2019, 9:42 pm
Sanofi, in a case that asked the Court to review the Federal Circuit's jurisprudence related to the written description requirement of 35 U.S.C. [read post]
12 Mar 2023, 9:15 am
The brief responds to arguments raised both by rival pharmaceutical firm Sanofi and the U.S. federal government in Amgen’s appeal of the invalidation of its patent claims as a matter of law under 35 U.S.C. [read post]
12 Mar 2023, 9:15 am
The brief responds to arguments raised both by rival pharmaceutical firm Sanofi and the U.S. federal government in Amgen’s appeal of the invalidation of its patent claims as a matter of law under 35 U.S.C. [read post]
12 Mar 2024, 9:13 pm
Sanofi Pasteur Inc., affirming the Patent Trial and Appeal Board's (PTAB) determination that all claims of U.S. [read post]
12 Aug 2019, 12:32 am
In its appellee’s brief, Sanofi-Aventis argued that the expert report was biased due to how fast it was prepared. [read post]
4 Jan 2017, 11:26 am
link: http://www.reuters.com/article/us-sanofi-fr-amgen-idUSKBN14N1VDFiercePharma has some interesting comments, includingJudge Sue Robinson threatened to block Praluent sales unless the parties struck a royalty agreement. (...)And Robinson has yet to decide whether to halt Praluent sales. link: http://www.fiercepharma.com/pharma/judge-upholds-pcsk9-patent-ruling-amgen-s-favor-as-sanofi-regeneron-get-set-to-appealAlso, note the piece in Barron'sRegeneron: Who Cares… [read post]
18 Apr 2022, 10:50 am
Sanofi, the Supreme Court has been asked to review Federal Circuit precedent on the enablement doctrine found in 35 U.S.C. [read post]
26 Mar 2020, 5:56 pm
Sanofi-Aventis U.S. [read post]
